• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by AMREP Corporation (Amendment)

    5/17/24 4:00:29 PM ET
    $AXR
    Homebuilding
    Real Estate
    Get the next $AXR alert in real time by email
    SC 13D/A 1 tm2414738d1_sc13da.htm SC 13D/A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934 (Amendment No. 6)*

     

    AMREP Corporation
    (Name of Issuer)

     

    Common Stock, par value $0.10 per share
    (Title of Class of Securities)

     

    032159105
    (CUSIP Number)

     

    James H. Dahl

    4314 Pablo Oaks Court

    Jacksonville, FL 32224

    (904) 329-4470

     

    With copy to:

     

    Ivan A. Colao, Esq.

    Holland & Knight LLP

    50 North Laura Street, Suite 3900

    Jacksonville, FL 32202

    (904) 353-2000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    May 15, 2024
    (Date of Event which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ¨.

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    SCHEDULE 13D

     

    CUSIP No. 032159105

      

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    James H. Dahl
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  x

    (b)  ¨

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF, OO
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
    ¨
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    711,699
    8 SHARED VOTING POWER
    173,750
    9 SOLE DISPOSITIVE POWER
    711,699
    10 SHARED DISPOSITIVE POWER
    173,750

    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    885,449
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    ¨
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    16.8%*
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN

     

    * This calculation is based on 5,271,309 Shares of Common Stock outstanding as of March 6, 2024 reported in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended January 31, 2024, filed with the Securities and Exchange Commission (the “SEC”) on March 8, 2024.

     

     

     

     

    CUSIP No. 032159105

      

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Rainey E. Lancaster
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  x

    (b)  ¨

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
    ¨
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    0
    8 SHARED VOTING POWER
    173,750
    9 SOLE DISPOSITIVE POWER
    0
    10 SHARED DISPOSITIVE POWER
    173,750

    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    173,750
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    ¨
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    3.3%*
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN

     

    * This calculation is based on 5,271,309 Shares of Common Stock outstanding as of March 6, 2024 reported in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended January 31, 2024, filed with the SEC on March 8, 2024.

     

     

     

     

    This Amendment No. 6 to Schedule 13D (“Amendment No. 6”) amends and supplements the information set forth in the Schedule 13D filed by (i) James H. Dahl and (ii) Rainey E. Lancaster (each, a “Reporting Person” and collectively, the “Reporting Persons”) with the SEC on May 20, 2021 (the “Schedule 13D”), as amended by Amendment No. 1 to Schedule 13D filed by the Reporting Persons with the SEC on September 2, 2021 (“Amendment No. 1”), as further amended by Amendment No. 2 to Schedule 13D filed by the Reporting Persons with the SEC on December 13, 2021 (“Amendment No. 2”), as further amended by Amendment No. 3 to Schedule 13D filed by the Reporting Persons with the SEC on March 31, 2022 (“Amendment No. 3”), as further amended by Amendment No. 4 to Schedule 13D filed by the Reporting Persons with the SEC on January 9, 2024 (“Amendment No. 4”) and as further amended by Amendment No. 5 to Schedule 13D filed by the Reporting Persons with the SEC on February 1, 2024 (“Amendment No. 5,” and, together with Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4 and the Schedule 13D, the “Amended Schedule 13D”), relating to the Common Stock, par value $0.10 per share (“Shares”), of AMREP Corporation (the “Issuer”), having a principal executive office at 850 West Chester Pike, Suite 205, Havertown, Pennsylvania 19083. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Amended Schedule 13D. Except as specifically provided herein, this Amendment No. 6 does not modify any of the information previously reported in the Amended Schedule 13D.

     

    Item 3. Source and Amount of Funds or Other Considerations.

     

    Item 3 of the Amended Schedule 13D is amended and restated to read as follows:

     

    The Reporting Persons may be deemed to beneficially own 885,449 Shares, in aggregate. The amount and source of the funds for the transactions pursuant to which the Reporting Persons may be deemed to beneficially own such Shares were approximately $11,471,377.90 in aggregate purchase price for 885,449 Shares, derived from: (i) in the case of James H. Dahl, personal funds of James H. Dahl and funds from the following trusts for which James H. Dahl serves as trustee: IRA FBO James H. Dahl Pershing LLC as Custodian ROTH Conversion Account, IRA FBO James H. Dahl Pershing LLC as Custodian and Dahl Family Foundation, Inc.; and (ii) in the case of Rainey E. Lancaster, personal funds of Rainey E. Lancaster.

     

    Item 5. Interest in Securities of the Issuer.

     

    Item 5 of the Amended Schedule 13D is amended and restated to read as follows: 

     

    (a)         According to the most recently filed Quarterly Report on Form 10-Q of the Issuer for the quarter ended January 31, 2024, filed with the SEC on March 8, 2024, the Issuer had 5,271,309 Shares outstanding as March 6, 2024. Each Reporting Person may be deemed to have the following beneficial ownership of Shares of the Issuer: (i) James H. Dahl may be deemed to beneficially own 885,449 Shares, in aggregate (or 16.8% of the total number of Shares outstanding); and (ii) Rainey E. Lancaster may be deemed to beneficially own 173,750 Shares (or 3.3% of the total number of Shares outstanding). All holdings in this Statement on Schedule 13D are reported as of the closing of business on May 17, 2024.

     

    (b)         James H. Dahl has sole power to vote and dispose of 711,699 Shares, including: (i) 388,428 Shares held directly, (ii) 204,151 Shares held by IRA FBO James H. Dahl Pershing LLC as Custodian ROTH Conversion Account, (iii) 25,000 Shares held by IRA FBO James H. Dahl Pershing LLC as Custodian, and (iv) 94,120 Shares held by Dahl Family Foundation, Inc. Neither James H. Dahl nor any member of his family have any pecuniary interest in Shares held by Dahl Family Foundation, Inc. The Reporting Persons have shared power to vote and dispose of 173,750 Shares held by Rainey E. Lancaster.

     

     

     

    (c)      The Reporting Persons effected the following transactions in the Shares in open market transactions on the dates indicated, and such transactions are the only transactions in the Shares by the Reporting Persons during the sixty days prior to and including May 17, 2024 (date range: March 18, 2024 through May 17, 2024):

     

    Date of Transaction   Number of Shares
    Purchased
       Price Per Share 
    03/22/24    1,690   $20.1641 
    03/22/24    1,810   $20.9412 
    03/25/24    2,800   $20.53663 
    03/26/24    2,500   $21.43 
    04/01/24    5,000   $23.50 
    04/03/24    3,000   $22.20 
    04/11/24    1,800   $21.98594 
    04/16/24    142   $20.98 
    04/18/24    2,400   $21.81645 
    04/29/24    5,000   $21.046 
    05/03/24    10,000   $20.95 
    05/07/24    4,621   $20.60 
    05/10/24    3,200   $20.97337 
    05/15/24    4,400   $20.95348 
                

     

    1 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.45 to $20.39 per share.

    2 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.45 to $21.28 per share.

    3 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.50 to $20.61 per share.

    4 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.79 to $22.00 per share.

    5 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.45 to $22.24 per share.

    6 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.00 to $21.05 per share.

    7 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.73 to $21.00 per share.

    8 This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.65 to $21.25 per share.

     

    For the weighted average prices set forth above, the Reporting Persons undertake to provide upon request by the SEC Staff full information regarding the number of shares purchased at each separate price.

     

    (d)         No person other than the Reporting Persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement on Schedule 13D.

     

    (e)         Not applicable.

     

    Item 7. Material to Be Filed as Exhibits.

     

    Exhibit
    Number
      Description
    99.1   Joint Filing Agreement, dated May 20, 2021, incorporated herein by reference to Exhibit 99.1 of the Schedule 13D filed on May 20, 2021

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

    May 17, 2024

     

      /s/ James H. Dahl
      JAMES H. DAHL

     

      /s/ Rainey E. Lancaster
      RAINEY E. LANCASTER

     

     

    Get the next $AXR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AXR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AXR
    Leadership Updates

    Live Leadership Updates

    See more
    • AMREP ANNOUNCES APPOINTMENT OF CHRISTOPHER VITALE AS A DIRECTOR

      PLYMOUTH MEETING, Pa., July 13, 2021 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today announced that Christopher V. Vitale has been appointed as a director of AMREP. Mr. Vitale is AMREP's Chief Executive Officer and President. AMREP's Chairman, Edward B. Cloues, II, commented, "Chris, who has served as our Chief Executive Officer since September 2017, has been integral to AMREP's business operations since he joined the Company in 2013. He has a deep understanding of our real estate business and the industry in which we operate and has adeptly applied that knowledge in his leadership and expansion of the business. We look forward to his further participation and contributions to AMRE

      7/13/21 5:06:25 PM ET
      $AXR
      Homebuilding
      Real Estate

    $AXR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AMREP Reports Third Quarter Fiscal 2025 Results

      HAVERTOWN, Pa., March 07, 2025 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $717,000, or $0.13 per diluted share, for its 2025 fiscal third quarter ended January 31, 2025 compared to net income of $92,000, or $0.02 per diluted share, for the same period of the prior year. For the first nine months of 2025, AMREP had net income of $8,823,000, or $1.64 per diluted share, compared to net income of $2,546,000, or $0.48 per diluted share, for the same period of 2024. Revenues were $7,520,000 and $38,516,000 for the third quarter and first nine months of 2025 and $12,689,000 and $31,833,000 for the third quarter and first nine months of 2024. More information ab

      3/7/25 4:25:21 PM ET
      $AXR
      Homebuilding
      Real Estate
    • AMREP Reports Second Quarter Fiscal 2025 Results

      HAVERTOWN, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $4,042,000, or $0.75 per diluted share, for its 2025 fiscal second quarter ended October 31, 2024 compared to net income of $1,108,000, or $0.21 per diluted share, for the same period of the prior year. For the first six months of 2025, AMREP had net income of $8,106,000, or $1.51 per diluted share, compared to net income of $2,454,000, or $0.46 per diluted share, for the same period of 2024. Revenues were $11,906,000 and $30,997,000 for the second quarter and first six months of 2025 and $8,854,000 and $19,143,000 for the second quarter and first six months of 2024. More informat

      12/13/24 4:40:04 PM ET
      $AXR
      Homebuilding
      Real Estate
    • AMREP Reports First Quarter Fiscal 2025 Results

      HAVERTOWN, Pa., Sept. 13, 2024 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $4,064,000, or $0.76 per diluted share, for its 2025 fiscal first quarter ended July 31, 2024 compared to net income of $1,346,000, or $0.25 per diluted share, for the same period of the prior year. Revenues were $19,091,000 for the first quarter of 2025 and $10,289,000 for the first quarter of 2024. More information about the Company's financial performance may be found in AMREP Corporation's financial statements on Form 10-Q which have today been filed with the Securities and Exchange Commission and will be available on AMREP's website (www.amrepcorp.com/sec-filings/). As a res

      9/13/24 4:40:51 PM ET
      $AXR
      Homebuilding
      Real Estate

    $AXR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Dahl James H bought $53,906 worth of shares (1,800 units at $29.95) (SEC Form 4)

      4 - AMREP CORP. (0000006207) (Issuer)

      10/4/24 7:03:39 PM ET
      $AXR
      Homebuilding
      Real Estate
    • Large owner Dahl James H bought $59,396 worth of shares (2,000 units at $29.70) (SEC Form 4)

      4 - AMREP CORP. (0000006207) (Issuer)

      9/27/24 5:02:01 PM ET
      $AXR
      Homebuilding
      Real Estate
    • Large owner Dahl James H bought $92,250 worth of shares (3,000 units at $30.75) (SEC Form 4)

      4 - AMREP CORP. (0000006207) (Issuer)

      9/24/24 5:19:09 PM ET
      $AXR
      Homebuilding
      Real Estate

    $AXR
    SEC Filings

    See more
    • AMREP Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - AMREP CORP. (0000006207) (Filer)

      3/7/25 4:01:37 PM ET
      $AXR
      Homebuilding
      Real Estate
    • SEC Form 10-Q filed by AMREP Corporation

      10-Q - AMREP CORP. (0000006207) (Filer)

      3/7/25 4:00:25 PM ET
      $AXR
      Homebuilding
      Real Estate
    • AMREP Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - AMREP CORP. (0000006207) (Filer)

      12/13/24 4:33:29 PM ET
      $AXR
      Homebuilding
      Real Estate